Clinical Trials Browser

INDUSTRY × Lymphoma, Large B-Cell, Diffuse × ibritumomab tiuxetan × Clear all

NCT00322218 2022-01-19

Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Phase 3 Terminated

68 enrolled 9 charts

Lymphoma, Large B-Cell, Diffuse

NCT01510184 2021-12-16

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Phase 3 Terminated

79 enrolled 9 charts

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse